Narjust Duma
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Diversity and Career in Medicine 12
- Oncology 18
- COVID-19 and healthcare impacts 8
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Julian R. Molina (4 shared papers)Rafael Santana-Dávila (1 shared paper)Jesus Vera Aguilera (4 shared papers)Yucai Wang (4 shared papers)Aaron Scott Mansfield (7 shared papers)Alex A. Adjei (6 shared papers)Ronald S. Go (5 shared papers)Thorvardur Ragnar Halfdanarson (3 shared papers)
- Journals
- The Oncologist (8 papers)JAMA Oncology (4 papers)Journal of Clinical Oncology (4 papers)Annals of Surgical Oncology (3 papers)JAMA Network Open (3 papers)
- Partner nations
- United StatesUnited KingdomMexico
In The Last Decade
Narjust Duma
75 papers receiving 5.2k citations
Narjust Duma's Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 1.7k
- Pulmonary and Respiratory Medicine 691
- Gender Studies 143
- Cancer Research 184
- Infectious Diseases 305
Countries citing papers authored by Narjust Duma
This map shows the geographic impact of Narjust Duma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narjust Duma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narjust Duma more than expected).
Fields of papers citing papers by Narjust Duma
This network shows the impact of papers produced by Narjust Duma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narjust Duma. The network helps show where Narjust Duma may publish in the future.
Co-authors
The 25 scholars most cited alongside Narjust Duma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment Hit paper breakdown → | 2019 | 1669 |
| 2 | Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Hit paper breakdown → | 2020 | 1348 |
| 3 | Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials Hit paper breakdown → | 2019 | 696 |
| 4 | Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years Hit paper breakdown → | 2017 | 327 |
| 5 | 2019 | 113 | |
| 6 | 2022 | 109 | |
| 7 | 2019 | 103 | |
| 8 | 2022 | 98 | |
| 9 | 2019 | 69 | |
| 10 | 2020 | 57 | |
| 11 | 2022 | 47 | |
| 12 | 2018 | 45 | |
| 13 | 2018 | 45 | |
| 14 | 2021 | 43 | |
| 15 | 2022 | 39 | |
| 16 | 2021 | 35 | |
| 17 | 2021 | 31 | |
| 18 | 2021 | 28 | |
| 19 | 2018 | 26 | |
| 20 | 2020 | 26 |
About Narjust Duma
Narjust Duma is a scholar working on Gender Studies, Oncology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Hematology, having authored 79 papers that have together received 5.4k indexed citations. Recurring topics across this work include Diversity and Career in Medicine (12 papers), COVID-19 and healthcare impacts (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Ethics in Clinical Research (4 papers), Multiple Myeloma Research and Treatments (3 papers), Male Breast Health Studies (2 papers) and Advances in Oncology and Radiotherapy (2 papers). The work is most often cited by research in Oncology (1.7k citations), Pulmonary and Respiratory Medicine (691 citations), Gender Studies (143 citations), Cancer Research (184 citations) and Infectious Diseases (305 citations). Narjust Duma has collaborated with scholars based in United States, United Kingdom and Mexico. Frequent co-authors include Julian R. Molina, Rafael Santana-Dávila, Jesus Vera Aguilera, Yucai Wang, Aaron Scott Mansfield, Alex A. Adjei, Ronald S. Go, Thorvardur Ragnar Halfdanarson, Jonas Paludo and Konstantinos Leventakos. Their work appears in journals such as The Oncologist, JAMA Oncology, Journal of Clinical Oncology, Annals of Surgical Oncology and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.